1. Home
  2. PLSE vs ECPG Comparison

PLSE vs ECPG Comparison

Compare PLSE & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • ECPG
  • Stock Information
  • Founded
  • PLSE 2014
  • ECPG 1998
  • Country
  • PLSE United States
  • ECPG United States
  • Employees
  • PLSE 75
  • ECPG N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • ECPG Finance Companies
  • Sector
  • PLSE Health Care
  • ECPG Finance
  • Exchange
  • PLSE Nasdaq
  • ECPG Nasdaq
  • Market Cap
  • PLSE 1.3B
  • ECPG 905.2M
  • IPO Year
  • PLSE 2016
  • ECPG 1999
  • Fundamental
  • Price
  • PLSE $19.87
  • ECPG $42.67
  • Analyst Decision
  • PLSE Buy
  • ECPG Strong Buy
  • Analyst Count
  • PLSE 1
  • ECPG 3
  • Target Price
  • PLSE $22.00
  • ECPG $62.67
  • AVG Volume (30 Days)
  • PLSE 254.2K
  • ECPG 324.9K
  • Earning Date
  • PLSE 10-29-2025
  • ECPG 11-05-2025
  • Dividend Yield
  • PLSE N/A
  • ECPG N/A
  • EPS Growth
  • PLSE N/A
  • ECPG N/A
  • EPS
  • PLSE N/A
  • ECPG N/A
  • Revenue
  • PLSE N/A
  • ECPG $1,467,587,000.00
  • Revenue This Year
  • PLSE N/A
  • ECPG $27.55
  • Revenue Next Year
  • PLSE $700.00
  • ECPG $5.84
  • P/E Ratio
  • PLSE N/A
  • ECPG N/A
  • Revenue Growth
  • PLSE N/A
  • ECPG 15.50
  • 52 Week Low
  • PLSE $13.77
  • ECPG $26.45
  • 52 Week High
  • PLSE $25.00
  • ECPG $51.77
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 70.79
  • ECPG 45.24
  • Support Level
  • PLSE $17.10
  • ECPG $40.48
  • Resistance Level
  • PLSE $19.94
  • ECPG $42.20
  • Average True Range (ATR)
  • PLSE 0.83
  • ECPG 1.32
  • MACD
  • PLSE 0.20
  • ECPG -0.44
  • Stochastic Oscillator
  • PLSE 78.67
  • ECPG 16.89

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.

Share on Social Networks: